NCT00421174 2021-11-01
BMTCTN0403
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3 Completed
Clinical Trials
10 trialsNCT00837434 2021-09-22
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 4 Completed
NCT00031551 2017-12-06
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00111956 2017-10-06
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2/3 Completed
NCT00001893 2017-07-02
Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00001862 2008-03-04
TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00001901 2008-03-04
Etanercept to Treat Wegener's Granulomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00001955 2008-03-04
Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00005007 2007-12-28
Etanercept for Wegener's Granulomatosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phase 2/3 Completed
NCT00012506 2005-06-24
The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
National Eye Institute (NEI)
Phase 3 Unknown